A next-generation plant transformation platform combining an engineered auxotrophic, non-necrotic Agrobacterium strain with morphogenic regulators delivered via functionalized carbon nanotubes. Designed to improve transformation efficiency and regeneration in recalcitrant crop species, with applications in cacao, yam, tomato, hemp, and other commercially important plants.
This offering combines a multi-pronged improvement of Agrobacterium as a plant transformation vector with advanced morphogenic regulator delivery to address one of the most persistent bottlenecks in plant biotechnology: regenerating transformed plants from recalcitrant species. The platform integrates auxotrophic Agrobacterium strains, RecA inactivation, reduced hypersensitive response, and SacB-based negative selection into a single optimized strain. Complementing this, morphogenic regulators and signal transduction modulators are delivered transiently via functionalized carbon nanotubes, enabling enhanced regeneration without stable integration. The combined approach targets improved transformation efficiency, reduced tissue necrosis, and broader applicability across difficult-to-transform crops.
Engineered Agrobacterium strain features:
Morphogenic regulator delivery:
The platform is at an early-to-mid stage of development. Individual components have been validated: auxotrophic attenuation was demonstrated in prior published work, the non-necrotic strain and C58 cysteine auxotroph have been sequenced, and morphogenic regulators such as BBM and LEC2 have shown enhanced regeneration in highly recalcitrant cacao. RecA/SacB homologous recombination tools and megaplasmid eviction systems have been obtained from collaborating labs. Remaining work includes completing the redesigned knockin vector at the RecA locus, swapping helper plasmids, validating hypersensitive response reduction with the luminol assay, and demonstrating carbon nanotube-mediated transient delivery of morphogenic regulators in a recalcitrant species such as yam. The platform is not yet commercially deployed and will require further validation before licensing or co-development partnerships.